ArticleClinical cancer research : an official journal of the American Association for Cancer Research2010

The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrations.

Begoña Comin-Anduix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.